Prepharmacist Pharmacy Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 8 Year, 11 Months
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 0.95 M
- Revenue Growth 202.89%
- Profit Growth 1537.87%
- Ebitda 184.30%
- Net Worth 123.74%
- Total Assets 62.33%
About Prepharmacist Pharmacy
Prepharmacist Pharmacy Private Limited (PPPL) is a Private Limited Indian Non-Government Company incorporated in India on 15 March 2016 (Eight years and 11 months 2 days old ). Its registered office is in Unnao, Uttar Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹0.95 M.
Alok Tiwari and Jitendra Singh serve as directors at the Company.
Company Details
-
Location
Unnao, Uttar Pradesh, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U85191UP2016PTC077217
-
Company No.
077217
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
15 Mar 2016
-
Date of AGM
30 Sep 2022
-
Date of Balance Sheet
31 Mar 2022
-
Listing Status
Unlisted
-
ROC Code
Roc Kanpur
Industry
Who are the key members and board of directors at Prepharmacist Pharmacy?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Alok Tiwari
|
Director | 15-Mar-2016 | Current |
|
Jitendra Singh
|
Director | 15-Mar-2016 | Current |
Financial Performance of Prepharmacist Pharmacy.
Prepharmacist Pharmacy Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 202.89% increase. The company also saw a substantial improvement in profitability, with a 1537.87% increase in profit. The company's net worth Soared by an impressive increase of 123.74%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Prepharmacist Pharmacy?
In 2021, Prepharmacist Pharmacy had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹0.95 M
₹0
Charges Breakdown by Lending Institutions
- United Bank Of India : 0.10 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 14 Dec 2017 | United Bank Of India | ₹0.95 M | Open |
How Many Employees Work at Prepharmacist Pharmacy?
Unlock and access historical data on people associated with Prepharmacist Pharmacy, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Prepharmacist Pharmacy, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Prepharmacist Pharmacy's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
